Telisotuzumab Adizutecan for MET amp solid - Clinical Trial
¿Cuál es el Propósito de este estudio?
What happens during the study?
- You'll get the study medicine through an IV every 3 weeks
- Doctors will take blood and urine samples
- You'll have regular CT or MRI scans to check your health
Locally advanced or metastatic solid tumors that harbor MET amplification
¿Quién puede participar en el Estudio?
Who can join this study?
- Adults who are 18 or older
- Have a type of cancer that has spread and shows a special change called MET amplification
- Have already tried at least one treatment for their cancer
- Don’t have any other good treatment options that are likely to help them live longer
¿Qué Implica?
Why is this study happening?
Doctors are testing a new medicine called Telizotuzumab Adjzutecan (ABBV-400) to see if it is safe and works well for people with certain types of cancer that have spread and have a special change in their cells called MET amplification.
Detalles del Estudio
